Watch this month's Milk Quality Focus video to stay ahead of mastitis outbreaks by identifying the source infection.
Make sure you
never miss a post.
SUBSCRIBE NOW

Culture the bug to know the drug

February 14, 2014
POSTED BY: Ken Learmont | DVM | Dairy Technical Services | Zoetis

Identify which mastitis-causing pathogens you’re dealing with through on-farm culturing and stay ahead of mastitis outbreaks. Get started with culturing by determining which cows entering your parlor or milk barn pose the most risk of having a mastitis infection. Those at most risk may include first-calf heifers and older cows. And, you especially want to check them for staph infections and Mycoplasma.

Culture results can serve as a good heads-up for the pathogens lurking on your dairy so you and your veterinarian can be prepared with preventative measures and appropriate treatment. A successful lactating cow mastitis treatment protocol is tailored to mastitis-causing pathogens common on the dairy operation. Be sure to monitor through culturing so you can match the drug to the bug.

Of course, you can’t always afford to wait for culture data to come back. Waiting to treat can give a mastitis infection extra time to really do damage to the cow’s health, productivity and your bottom line. Keep a broad-spectrum antibiotic on hand, such as SPECTRAMAST® LC (ceftiofur hydrochloride) Sterile Suspension, that’s effective against both Gram-positive and Gram-negative mastitis, so you can treat early for better success.

Work with your veterinarian to set up ongoing culture programs and establish treatment protocols.

IMPORTANT SAFETY INFORMATION: People with known hypersensitivity to penicillin or cephalosporins should avoid exposure to SPECTRAMAST LC. Product requires a 72-hour milk discard period and a 2 day pre-slaughter withdrawal period following the last treatment. Use of this product in a manner other than indicated on the label, or failure to adhere to proper milk discard period, will result in violative residues. See full Prescribing Information, here.

COMMENTS

Have a Comment? Subscribe